Tango Therapeutics
Tango Therapeutics is seeking a visionary oncology leader to serve as Vice President, Clinical Development, overseeing the clinical development strategy for the vopimetostat program from early through late-stage trials. Reporting to the President of Research & Development, the role involves shaping enterprise-wide clinical strategy, leading cross‑functional teams, and representing the company within the oncology community.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
40% above the average for this role
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Associate Vice President, Global Clinical Development, Oncology Assets
MSD
Medical Director/Senior Medical Director, Clinical Development (Prostate)
ORIC Pharmaceuticals Inc
Global Development Team Lead, Clinical Development – Gastrointestinal Cancers
Revolution Medicines
Senior or Executive Medical Director
Iambic Therapeutics
Clinical Director Oncology (Principal Scientist, MD)
MSD
Clinical Research Physician - Oncology
Eli Lilly and Company